Increasing Prevalence of CVD Driving Angioplasty Balloons Market
There has been a steady increase in the incidence of cardiovascular diseases in recent years, with heart diseases becoming a major cause of fatalities, in both, developed and developing countries, globally. With this prevalence only set to increase in the future, the demand for balloon angioplasty for the treatment of severe cardiovascular conditions is on the rise, the impact of which has been directly proportional to the growth of the global angioplasty balloons market.
Major players in the global angioplasty balloons market are improving their product offerings by incorporating advanced technologies to pace up with this growing demand, while aligning with the pervasive trend of 'value-based' healthcare. These players are increasingly focusing on newer angioplasty balloons made of different materials and new products that work differently, while also looking to improve on their existing products, in order to have a positive impact on patient outcomes.
For detailed insights on market taxonomy, request a sample copy of the report here.
Preference for Drug-coated Balloons Increasing at a Rapid Rate
Drug-coated angioplasty balloons, which are considered to be a significant upgrade on normal angioplasty balloons, have been gaining traction in recent years. The popularity of these balloons can be attributed to their various benefits, including superior safety and effectiveness, resulting in improved blood flow for better medical outcomes. An analysis of the historical data reveals that, the drug coated balloons segment, which in 2019, occupied ~30% of the total market share, is set to register a Y-o-Y growth of ~4% in 2020.
Even as drug-coated balloons continue to gain popularity, the demand for cutting balloons has been gradually declining. At the time of their advent, cutting balloons witnessed exceptional interest, as they were a step up as compared to conventional uncoated normal balloons; however, the stiffness of the device, coupled with the risk of complex lesions, led to their popularity declining over the years. However, as a technological advancement that became a stepping stone to other types of balloons, cutting balloons have, nevertheless, had a significant impact on the evolution of the angioplasty balloons market.
Competitive Pricing Impeding Market from Realizing its True Potential
A decline in the average selling price of angioplasty balloons has been observed in recent years, which is likely to act as a restraint to the growth of the global market. While the prevalence of the disease and demand for treatment is set to rise, this decline in average price is expected to have a negative impact on the overall revenue of the landscape. This can be explained by various players looking to retain their competitive edge in regional markets, by adopting competitive pricing strategies, adversely impacting the revenue of the overall angioplasty balloons market.
For detailed regional analysis, request a sample copy of the report here.
Global Angioplasty Balloons Market - Regional Analysis
The regional markets occupying the largest share of the total revenue of the global angioplasty balloons market are North America and Europe. This can be attributed to the increasing awareness of treatment options and general health awareness in these regions, along with the impact of the rising prevalence of related illnesses. The robust expansion of these markets, however, can also be credited to the presence of established players in these regions, and the ready acceptance of newer technological advances in treatment options. This trend is likely to prevail over the forecast years too, as North America and Europe will continue to remain lucrative markets for players in the global angioplasty balloons market.
However, there has also been a surge in the demand from countries in the APAC region, including India, China, Japan, Australia, and New Zealand, in recent years. APAC is anticipated to be a lucrative market in the global angioplasty balloons landscape during the forecast years, expected to register a CAGR of ~5% throughout 2020 to 2025. This can be primarily credited to the improving healthcare infrastructure and growing spending power of the population in the region. The fast pace of growth of this regional market can also be attributed to growing consciousness regarding Percutaneous Coronary Intervention (PCI) procedures, coupled with the increasing adoption of cost-effective and minimally-invasive procedures. Manufacturers in the angioplasty balloons market are looking to cash in on this trend, and establish themselves in APAC, to gain a stronger foothold in the global angioplasty balloons market.
Request research methodology of this report.
Angioplasty Balloons Market - Scope of the Report
Fact.MR’s report on the angioplasty balloons market provides forecast details and a comprehensive outlook on the evolution of the landscape. It provides historical data from 2013 to 2019, estimated data for 2020, and forecast data up to 2025, in terms of revenue and volume. This research report offers data on the key trends that are influencing the growth of the angioplasty balloons market, along with the micro- and macro-economic indicators of the same. This report sheds light on how these trends are expected to impact every aspect in the value chain, from the suppliers to the end users, and the effect it is likely to have on the global angioplasty balloons market.
This report is a study on the current scenario, end user requirements, and issues faced by the supply chain as a whole, in the angioplasty balloons landscape. It is meant to provide readers with an all-inclusive view of the market as a whole, and a detailed understanding of the major players in the angioplasty balloons market space. This analysis of the key players includes not just data on product developments and market presence, but also a comparative assessment of the companies on a variety of parameters.
Angioplasty Balloons Market - Assessment of the Segmentation
The global angioplasty balloons market is segmented based on the balloon type, material, and geography.
Middle East and North Africa
Rest of the World
This study on the global angioplasty balloons market has product-, material-, and country-specific data, along with market size valuation and forecast price point assessment of the same. The price index and the impact analysis of key regional and country-wise dynamics, also mentioned in the report, have been obtained through quotes from stakeholders and experts in the global angioplasty balloons market. An in-depth analysis on the Y-o-Y growth projections of the angioplasty balloons market are also included in this report.
Angioplasty Balloons Market - Research Methodology
The data presented in this report on the global angioplasty balloons market, pertaining to regional- and country-level information of the performance and expected growth of the segments, is collated and estimated though a combination of primary and secondary resources, across regions and countries. This collated information is analysed using both, the top-down and bottom-up approach, along with Porter’s Five Forces analysis and market attractiveness analysis.
This Fact.MR global angioplasty balloons market competition scenario analysis is based on historical data and on current trends in the market, and the data and insights obtained has been gained through secondary sources. The system of data triangulation is also used for the cross-checking of the collected and analysed data, from both, the supply and the demand sides of the angioplasty balloon market.
For the assessment of the market size and volume estimations, data has been gathered from the revenues generated by leading players, coupled with their production capacities. There are also other qualitative findings and perspectives gathered from interviews with people within the market, including business development managers / executives, CEOs, and plant managers, which has been incorporated into this report. This information has been adhered to by the analysts while developing the report on the global angioplasty balloons market. Secondary research is leveraged for ascertaining the overall size of the angioplasty balloons market.
The market viewpoint that is offered in this report on the angioplasty balloons market considers the impact of the macro-economic factors that are expected to influence the evolution of the market. The report includes a section on global pricing analysis, restraint analysis, and an opportunity analysis of the angioplasty balloons market as well.
This report is designed to serve as an authentic and informative resource, enabling readers to make data-based decisions on the future of businesses in the global angioplasty balloons market.
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Secondary Research
1.3.2 Primary Research
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Angioplasty Balloons Market (2019 & 2025)
2.2 Global Angioplasty Balloons Market Revenue, by Types, 2019 (USD Million)
2.3 Comparative Analysis: Global Angioplasty Balloons Market Revenue, by Geography, 2019 & 2025 (Value %)
Chapter 3 Market Overview
3.2 Market Drivers
3.2.1 Increasing prevalence of coronary artery disease
3.2.2 Rise in aging population along with obesity rate
3.2.3 Continuous launch of new products
3.3 Market Restraints
3.3.1 Increasing penetration of players is resulting in decline in average selling price
3.4.1 Products in pipeline
3.4.2 Emerging countries
3.5 Porter’s Five Force Analysis of the Global Angioplasty Balloons Market
3.5.1 Bargaining power of suppliers
3.5.2 Bargaining power of buyers
3.5.3 Threat of substitutes
3.5.4 Threat of new entrants
3.5.5 Competitive rivalry
3.6 Market Attractiveness Analysis: Global Angioplasty Balloons Market, by Geography
3.7 Competitive Landscape
3.7.1 Market Share Analysis: Global Angioplasty Balloons Market, 2019 (Value %)
Chapter 4 Global Angioplasty Balloons Market, by Balloon Type
4.1.1 Global Angioplasty Balloons Market Revenue, by Type, 2013 – 2025 (USD Million)
4.1.2 Normal Balloons
184.108.40.206 Global Normal Balloons Market Revenue, 2013 – 2025 (USD Million)
4.1.3 Cutting Balloons
220.127.116.11 Global Cutting Balloons Market Revenue, 2013 – 2025 (USD Million)
4.1.4 Scoring Balloons
18.104.22.168 Global Scoring Balloons Market Revenue, 2013 – 2025 (USD Million)
4.1.5 Drug Coated Balloons
22.214.171.124 Global Drug Coated Balloons Market Revenue, 2013 – 2025 (USD Million)
Chapter 5 Global Angioplasty Balloons Market, by Material
5.1.1 Global Angioplasty Balloons Market Revenue, by Material, 2013 – 2025 (USD Million)
5.1.2 Non-Compliant Balloons
126.96.36.199 Global Non-Compliant Balloons Market Revenue, 2013 – 2025 (USD Million)
5.1.3 Semi-Compliant Balloons
188.8.131.52 Global Semi-Compliant Balloons Market Revenue, 2013 – 2025 (USD Million)
Chapter 6 Global Angioplasty Balloons Market, by Geography
6.1.1 Global Angioplasty Balloons Market Revenue, by Geography, 2013 – 2025 (USD Million)
6.2 North America
6.2.1 North America Angioplasty Balloons Market Revenue, by Country, 2013 – 2025 (USD Million)
6.3.1 Europe Angioplasty Balloons Market Revenue, by Country, 2013 – 2025 (USD Million)
6.4 Asia-Pacific (APAC)
6.4.1 Asia-Pacific Angioplasty Balloons Market Revenue, by Country, 2013 – 2025 (USD Million)
6.5 Latin America (LATAM)
6.5.1 LATAM Angioplasty Balloons Market Revenue, by Country, 2013 – 2025 (USD Million)
6.6.1 MENA Angioplasty Balloons Market Revenue, by Country, 2013 – 2025 (USD Million)
6.7 Rest of the World (RoW)
6.7.1 RoW Angioplasty Balloons Market Revenue, 2013 – 2025 (USD Million)
Chapter 7 Recommendations
7.1 Investing in Emerging Markets of Asia Pacific, Latin America, and Africa
7.2 Focus on improved and technologically advanced angioplasty balloons
Chapter 8 Company Profiles
8.1 Abbott Vascular
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 BIOTRONIK SE & Co.KG
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategy
8.2.5 Recent Developments
8.3 Boston Scientific Corporation
8.3.1 Company Profile
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Cook Medical, Inc.
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 Johnson & Johnson (Cordis Corporation)
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 C. R. Bard, Inc.
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategy
8.6.5 Recent Developments
8.7 ENDOCOR GmbH
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategy
8.8 Medtronic, plc
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Development
8.9 NATEC Medical Limited
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategy
8.9.5 Recent Development
8.10 Spectranetics Corporation
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.10.4 Business Strategy
8.10.5 Recent Development
Fact.MR offers custom research services that help clients to get specific research solutions
We are committed towards customer satisfaction and quality service.